- Home
- OTLK vs HYPR Comparison
OTLK vs HYPR Comparison
Compare OTLK & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTLK
- HYPR
- Stock Information
- Founded
- OTLK 2010
- HYPR 2014
- Country
- OTLK United States
- HYPR United States
- Employees
- OTLK N/A
- HYPR N/A
- Industry
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- HYPR Medical Specialities
- Sector
- OTLK Health Care
- HYPR Health Care
- Exchange
- OTLK Nasdaq
- HYPR Nasdaq
- Market Cap
- OTLK 48.3M
- HYPR 54.6M
- IPO Year
- OTLK 2016
- HYPR N/A
- Fundamental
- Price
- OTLK $1.53
- HYPR $0.74
- Analyst Decision
- OTLK Strong Buy
- HYPR Strong Buy
- Analyst Count
- OTLK 5
- HYPR 3
- Target Price
- OTLK $10.20
- HYPR $1.33
- AVG Volume (30 Days)
- OTLK 274.9K
- HYPR 183.7K
- Earning Date
- OTLK 05-19-2025
- HYPR 05-13-2025
- Dividend Yield
- OTLK N/A
- HYPR N/A
- EPS Growth
- OTLK N/A
- HYPR N/A
- EPS
- OTLK N/A
- HYPR N/A
- Revenue
- OTLK N/A
- HYPR $12,890,000.00
- Revenue This Year
- OTLK N/A
- HYPR $24.00
- Revenue Next Year
- OTLK $288.46
- HYPR $28.70
- P/E Ratio
- OTLK N/A
- HYPR N/A
- Revenue Growth
- OTLK N/A
- HYPR 16.84
- 52 Week Low
- OTLK $0.87
- HYPR $0.58
- 52 Week High
- OTLK $9.25
- HYPR $1.90
- Technical
- Relative Strength Index (RSI)
- OTLK 55.94
- HYPR 50.99
- Support Level
- OTLK $1.35
- HYPR $0.66
- Resistance Level
- OTLK $1.62
- HYPR $0.76
- Average True Range (ATR)
- OTLK 0.10
- HYPR 0.05
- MACD
- OTLK -0.00
- HYPR 0.01
- Stochastic Oscillator
- OTLK 54.55
- HYPR 61.23
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About HYPR Hyperfine Inc.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.